CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humans-Reference-Cited by-同舟云学术

CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humans

Published:2018-10-11 Issue:12 Volume:84 Page:2857-2866
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Chattopadhyay Niladri¹,Kanacher Tobias¹,Casjens Manuela²,Frechen Sebastian¹,Ligges Sandra¹,Zimmermann Torsten¹,Rottmann Antje¹,Ploeger Bart¹,Höchel Joachim¹,Schultze-Mosgau Marcus-Hillert¹^ORCID

Affiliation:

1. Bayer AG; Berlin Germany

2. CRS Clinical Research Services Berlin GmbH; Berlin Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13750/fullpdf

Reference41 articles.

1. Interaction of sodium warfarin and rifampin;O'Reilly;Ann Intern Med,1974

2. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Clinical drug interaction studies - study design, data analysis, and clinical implications. Guidance for industry. Draft guidance [online] https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf

3. Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administration;Baneyx;Eur J Pharm Sci,2014

4. BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies;Wagenfeld;Hum Reprod,2013

5. Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women;Schütt;Hum Reprod,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors;Cancer Chemotherapy and Pharmacology;2024-06-15

2. Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling;Clinical Pharmacology & Therapeutics;2024-01-08

3. Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates;European Journal of Drug Metabolism and Pharmacokinetics;2023-06-06

4. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: an in vitro study;2023-05-04

5. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study;Current Research in Toxicology;2023